483 results
8-K
EX-99
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
16 Mar 06
Results of Operations and Financial Condition
12:00am
that the filing of the Annual Report on Form
10-K for fiscal year 2005 would be delayed to provide additional time to
complete the evaluation and audit … . The Company expects to receive from its independent
public accounting firm, as part of their audit report, a disclaimer of opinion,
i.e., the non
8-K
EX-99.1
amyo8b4t8 noy7k
20 May 05
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
NT 10-K
2chzh 3zzn70poy0gt
17 Mar 05
Notice of late annual filing
12:00am
8-K
EX-99.1
k7rph2
6 Sep 05
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
8k7j 2vlsifm
6 Nov 00
Current report
12:00am
NT 10-Q
eh79sl6
11 May 05
Notice of late quarterly filing
12:00am
8-K
EX-99.1
1udmd
17 Mar 05
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
y8ya2 2zg
4 Aug 08
Ligand Pharmaceuticals Appoints Dr. Stephen Sabba to Board of Directors
12:00am
DEFA14A
q09y2xhx 4y67y5l
18 May 21
Additional proxy soliciting materials
5:00pm